)
Repligen (RGEN) investor relations material
Repligen Stifel 2025 Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Financial performance and growth drivers
Achieved 18% organic growth in the quarter, with all key product areas up double digits and operating margins at 14.2% despite a 70 basis point decline.
Year-to-date non-COVID organic growth reached 16%, with analytics and protein franchises outperforming expectations.
Exposure to small biotech is now below 10%, with total exposure including CDMOs around 11-12%.
Commercial execution and key account management strategies have driven strong order intake and sales, especially in emerging biotech.
Margin expansion is targeted at 100-200 basis points per year, with significant investments in talent to support future scaling.
Product segment performance and innovation
Filtration guidance was adjusted from 11% to 10% growth due to supply delays, but underlying demand remains strong.
Chromatography (Chrome) saw a standout year after organizational changes, with new big pharma clients adopting pre-packed columns.
Protein segment benefited from a shift to custom and catalog resin development, with strong demand for new ligands and resins.
All four main franchises are expected to grow at similar CAGRs, supporting the goal to double company size in five years.
Hardware revenue grew 20%, with strong traction for downstream systems and PAT technologies.
Market trends and strategic outlook
Biopharma and CDMO segments have recovered, while small biotech showed a notable rebound in orders and sales.
New modalities, including cell therapy and antibody drug conjugates, are expected to drive growth over the next 5-10 years.
Cell therapy is a focus area, with strong ATF technology adoption and new PAT solutions following recent acquisitions.
Lipid nanoparticle (LNP) technology is seen as a broad opportunity, requiring innovation in filters, purification, and single-use components.
Onshoring in the US is expected to generate significant equipment demand starting in 2026, with hardware and downstream systems as likely beneficiaries.
Next Repligen earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)